Factors predicting the functional outcome of intravenous thrombolysis in acute ischemic stroke at Somdejprabuddhalertla hospital

Authors

  • Jiraporn boontho โรงพยาบาลสมเด็จพระพุทธเลิศหล้า

Keywords:

Acute ischemic stroke, rt-PA (recombinant tissue plasminogen activator), Clinical outcome.

Abstract

Background: The use of recombinant tissue plasminogen activator (rt-PA) has been the standard of care for treatment of acute ischemic stroke for several years. The treatment outcomes for thrombolytic patients were variable. Factors that predicting the functional outcome were inconclusive.

Objectives: To determine which factors were predicting good and poor outcome of intravenous thrombolysis in stroke patients.

Methodology: This study was retrospective descriptive study in 135 patients who were diagnosed as acute ischemic stroke and received rt-PA treatment in Somdejprabuddhalertla hospital from December 2013 to December 2020.The set of statistical processes for this study were Student’s t test, Chi-square and multivariable logistic regression model.

Results: From 135 patients who were eligible for this study. The prevalence of good outcome (mRS 0-2) was 85 patients (63%), the prevalence of poor outcome (mRS 5-6) 18 patient (13.3%), death rate 5.9%. Factors that predicting the good outcome were NIHSS < 8 (OR 13.9, p-value < 0.01,95% CI 4.02-48.24) and early improvement (OR 18.63, p-value < 0.01,95% CI 2.06-16.86). Factors that predicting the poor outcome were atrial fibrillation (OR 26, p-value < 0.01,95% CI 2.8-24.6) and early worsening (OR 26.71, p-value < 0.01,95%
CI 4.75-150)

Conclusions: The factors that predicting the good outcome were NIHSS < 8 and early improvement. The factors that predicting the poor outcome were atrial fibrillation and early worsening.

References

จิราพร บุญโท. ผลการรักษาภาวะสมองขาดเลือดระยะเฉียบพลันโดยการใช้ยาละลายลิ่มเลือดในโรงพยาบาลสมเด็จพระพุทธเลิศหล้า. วารสารแพทย์เขต 4-5 2558;34(4):297-307.

จุฑามาศ จิรัสย์ชำนะ. ปัจจัยที่มีผลต่อความล่าช้าในการให้ยาละลายลิ่มเลือดทางหลอดเลือดดำในผู้ป่วยโรคหลอดเลือดสมองตีบหรืออุดตันเฉียบพลันที่มารับบริการที่ห้องฉุกเฉินโรงพยาบาลพระจอมเกล้า จังหวัดเพชรบุรี. วารสารแพทย์เขต 4-5 2562;38(4):326-35.

พรพงศ์ จิตต์ประทุม. ปัจจัยที่มีผลต่อผลการรักษาในผู้ป่วยหลอดเลือดสมองตีบเฉียบพลันที่ได้รับยาละลายลิ่มเลือดทางหลอดเลือดดำ ณ โรงพยาบาลชุมพรเขตรอุดมศักดิ์. วารสารประสาทวิทยาแห่งประเทศไทย 2562;35(2):30-9.

The National Institute of Neurological Disorder and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333(24):1581-7.

Hacke W, Kaste M, Fieschi C, et al. Thrombolysis with ateplase 3-4.5 Hours after acute ischemic stroke. N Engl J Med 2008;359(13):1317-29.

del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart

Association/American Stroke Association. Stroke 2009;40:2945–8.

Jauch EC, Saver JL, Adams HP, et al. guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.

Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–e110.

Emberson J, Lees KR, Lyden P, Bleckwell L, Albers G, Bluhmki E, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384(9958):1929-35.

Mehta A, Mahale R, Buddaraju K, Majeed A, Sharma S, Javali M, et al. Intravenous thrombolysis for acute ischemic stroke: review of 97 patients. J Neurosci Rural Pract 2017;8(1):38-43.

Bill O, Zufferey P, Faouzi M, Michel P. Severe stroke: patient profile and predictors of favorable outcome. J Thromb Haemost 2013;11(1):92-9.

Ojike N, Ravenell J, Seixas A, Masters-Israilov A, Rogers A, Jean-Louis G, et al. Racial disparity in stroke awareness in the US: an analysis of the 2014 National Health Interview Survey. J Neurol Neurophysiol. 2016;7(2):365.

Mandava P, Shah SD, Sarma AK, Kent TA. An outcome model for intravenous rt-PA in acute ischemic stroke.Transl Stroke Res 2015;6:451-7.

Abul-Kasim K, Brizzi M, Petersson J. Hyperdense middle cerebral artery sign is an ominous prognostic marker despite optimal workflow. Acta Neurol Scand 2010;122(2):1329.

Dharmasaroja PA, Muengtaweepongsa S, Dharmasaroja P. Early outcome after intravenous thrombolysis in patients with acute ischemic stroke. Neurol India 2011;59:351-4.

Muresan IP, Favrole P, Levy P, Andreux F, Marro B, Alamowitch S. Very early neurologic improvement after intravenous thrombolysis. Arch Neurol 2010;67:1323-8.

Delgado MG, Michel P, Naves M, Maeder P, Reichhart M, Wintermark M, et al. Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population. J Neurol Neurosurg Psychiatry 2010;81:2825.

Boddu DB, Srinivasarao Bandaru VC, Reddy PG, Madhusudan M, Rukmini MK, Suryaprabha T, et al. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: A hospital-based study from south India. Neurol India 2010;58:403-6.

Bill O, Zufferey P, Faouzi M, Michel P. Severe stroke: patient profile and predictors of favorable outcome. J Thromb Haemost 2013;11(1):92-9.

Nathanson D, Patrone C, Nyström T, et al. Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke. Stroke Res Treat 2014;747458.

Weimar C, Mieck T, Buchthal J, et al. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol 2005;62:393-7.

Downloads

Published

2021-08-24

How to Cite

1.
boontho J. Factors predicting the functional outcome of intravenous thrombolysis in acute ischemic stroke at Somdejprabuddhalertla hospital. J Thai Stroke Soc [Internet]. 2021 Aug. 24 [cited 2024 Jun. 23];20(2):5. Available from: https://he01.tci-thaijo.org/index.php/jtss/article/view/247552

Issue

Section

Original article